This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

2 Biotech Stocks Under $10 to Watch

Mast Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Mast Therapeutics ( MSTX), a biopharmaceutical company, develops novel therapies for serious or life-threatening diseases with significant unmet needs. This stock closed up 2% to 48 cents per share in Thursday's trading session.

Thursday's Range: $0.46-$0.49
52-Week Range: $0.41-$0.92
Volume: 3.52 million
Three-Month Average Volume: 732,059

Shares of MSTX spiked modestly higher on Thursday after Vista Partners updated coverage on the stock with a 12-month price target of $2.25 per share.

>>5 Stocsk Insiders Love Right Now

From a technical perspective, MSTX trended slightly higher here right above some near-term support at 44 cents per share with monster upside volume. This stock has been trending sideways for the last month and change, after it gapped down sharply in June from around 65 cents per share to its 52-week low of 41 cent per share. That sideways chart pattern has seen MSTX trend between 41 cents on the downside and 50 cents on the upside. Shares of MSTX are now quickly moving within range of triggering a major breakout trade above the upper-end of its sideways trading chart pattern. That trade will hit if MSTX manages to take out some near-term overhead resistance levels at 49 to 50 cents per share with high volume.

Traders should now look for long-biased trades in MSTX as long as it's trending above some near-term support levels at 44 cents to 42 cents, and then once it sustains a move or close above those breakout levels with volume that hits near or above 732,059 shares. If that breakout triggers soon, then MSTX will set up to re-fill its previous gap down zone from June that started near 65 cents per share. If that gap gets filled, then MSTX could hit 75 to 80 cents.

2 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs